Assay Biotechnology

Assay Biotechnology is a specialized provider of research-grade antibodies and immunoassay kits, operating in the highly competitive life science tools sector. Its core business model revolves around a catalog-based sales approach, offering a wide array of products including phospho-specific antibodies, recombinant monoclonal antibodies, and a diverse suite of conjugated secondary antibodies and ELISA formats. The company appears to be a privately-held, revenue-generating entity targeting the global basic research market with a focus on post-translational modification detection and assay development. Its strategy includes promotional discounts and sample-sized offerings to attract customers.

Proprietary antibody development, recombinant monoclonal production, and extensive conjugation technologies for creating research-grade antibodies and immunoassay kits, with a focus on post-translational modification detection.

Operates in the crowded life science research tools market, competing directly with giants like Thermo Fisher Scientific and Abcam, as well as specialized firms like Cell Signaling Technology. Differentiation is based on niche focus (PTM antibodies), proprietary conjugates (Ablight/AbFluor), and a broad catalog, but competes on price, specificity validation, and brand recognition.